Snapshot

The Emergency Use Authorization for Drugs & Vaccines for COVID-19 pathway has been developed by the of Philippines.

This pathway can be used where unregistered drugs and vaccines in a public health emergency. .

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Australia Canada EU-EMA Japan Singapore South Korea Switzerland United Kingdom United States WHO

Not stated.